By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DxS Ltd 

48 Grafton Street

Manchester    M13 9XX  United Kingdom
Phone: 0161-606-7201 Fax: 0161-606-7313



Company News
Pfizer Inc. (PFE) and QIAGEN Inc. (QGEN) Unit DxS Ltd Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients 2/5/2010 8:23:32 AM
QIAGEN Inc. (QGEN) Acquires DxS Ltd in Deal Worth up to $130 Million -- Creating Leadership in Personalized Healthcare 9/23/2009 8:09:00 AM
DxS Ltd Appoints Patrik Dahlen as Non-Executive Director 9/10/2009 1:41:41 PM
DxS Ltd Enters Into Collaboration With Bristol-Myers Squibb Company (BMY) And ImClone Systems Incorporated (IMCL) To Provide a K-RAS Companion Diagnostic For ERBITUX(R) 9/2/2009 2:02:23 PM
DxS Ltd Appoints David Jackson as Vice President of Business Development and Licensing 8/17/2009 10:58:42 AM
DxS Ltd Appointments Dave Clennell as Director of Quality 8/10/2009 12:17:10 PM
DxS Ltd Collaborates with AstraZeneca AB to Provide a Companion Diagnostic for IRESSA(TM) 7/31/2009 1:40:54 PM
Horizon Discovery Ltd. And DxS Ltd to Lead the Way in Setting Standards for Companion Diagnostic Tests 7/22/2009 11:37:23 AM
DxS Ltd And Epigenomics AG Cross-License Technology for in vitro Diagnostics 7/20/2009 12:17:53 PM
DxS Ltd's TheraScreen(R) K-RAS Companion Diagnostic Approved for Use With Amgen (AMGN)'s Vectibix(TM) in Canada 7/13/2009 1:02:10 PM